Countries China
KN026 was Granted Breakthrough Therapy Designation by CDE
Gastric cancer is one of the most common gastrointestinal malignancies in the world, and the number of new cases and deaths of gastric cancer in China...
November 08, 2023 | News
BioRay Starts Phase I Study for BRY812, Targeted Antibody Drug Conjugate
LIV-1, also known as SLC39A6 or ZIP6, is a multipass transmembrane protein belonging to the ZIP superfamily of zinc transporters, possesses zinc trans...
November 08, 2023 | News
Biotheus Partners with BioNTech to Develop Bispecific Antibody Targeting PD-L1 and VEGF in Solid Tumors
BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China Biotheus Inc. ("Biotheus"),...
November 07, 2023 | News
Sanyou Bio Cheers KangaBio's IND Approval for Next-Gen IL-12 Prodrug Cancer Immunotherapy
These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...
November 06, 2023 | News
XtalPi and CK Life Sciences Partner to Develop AI-Based Cancer Diagnostic Models
With the help of AI and machine learning models, this collaborative engagement will hopefully lead to the development of more advanced and intelligent solu...
November 06, 2023 | News
Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma
The company can initiate a project on four continents and easily transfer validated methods across labs, allowing therapeutic trials to extend to virtually...
November 03, 2023 | News
CStone Partners with 3SBio for Nofazinlimab in China
CStone to grant 3SBio exclusive rights for the development, registration, manufacturing, and commercialization of nofazinlimab (anti-PD-1 antibody) in ma...
November 02, 2023 | News
Rational Vaccines and Shenzhen Mellow Hope Partner on Herpes Vaccines in China
Rational Vaccines (RVx) and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (MH) announced they have reached an agreement to jointly develop, manufacture, ...
October 31, 2023 | News
First Patient Enrolled in Phase III Trial of Boan Biotech's Nivolumab
Nivolumab is a monoclonal antibody that can enhance the immune response of T cells against tumors by preventing the programmed cell death 1 (PD-1) receptor...
October 31, 2023 | News
Merck Expands Oncology Pipeline with Hengrui Partnership for PARP1 Inhibitor and ADC
Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and comme...
October 31, 2023 | News
Chime Biologics and Hope Medicine Accelerate First-in-Class Antibody Drug HMI-115 for Endometriosis and Androgenic Alopecia
Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine...
October 27, 2023 | News
Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China
This strategic partnership will enable Fapon to engage in the research, development, manufacturing, and commercialization of PSP raw materials and chemilum...
October 27, 2023 | News
Life Molecular Imaging and Sinotau Gain Regulatory Approval for Neuraceq® in China
Life Molecular Imaging (LMI) and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® (with Chinese trade name 欧韦宁®, florbetaben F-...
October 25, 2023 | News
Bio4t2 Trials CAR-T for Solid Tumors Without Lymphodepletion
The PrismCore platform generates CAR-T that recognizes overexpressed self-antigens on solid tumors. Bio-Engine adapts the CAR-T to transiently recogni...
October 18, 2023 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
